Sidra Medicine Recognized as ZEISS Reference Center in Qatar

Post by : Bianca Suleiman

Sidra Medicine, part of the Qatar Foundation, has been honored as a ZEISS labs@location Reference Customer through its Advanced Imaging Core (AIC), a significant milestone in the realm of medical imaging and biomedical inquiry.

This commendation positions Sidra Medicine alongside a prestigious group of elite research hospitals, academic medical facilities, and scientific institutions recognized for their exceptional performance in cutting-edge microscopy and imaging technologies.

The ZEISS labs@location Program facilitates cooperation between ZEISS and premier laboratories globally. This initiative aims at crafting advanced imaging solutions, offering scientific training, showcasing expert demonstrations, and promoting knowledge exchange in imaging science.

Lead of the Advanced Imaging Core at Sidra Medicine, Abbirami Sathappan, mentioned that this honor underscores the expertise, robust infrastructure, and collaborative research atmosphere cultivated within the center. She emphasized that this recognition will further enhance the institution's capability to assist researchers and clinicians with innovative imaging workflows that foster scientific advancements and clinically relevant studies.

The designation follows a thorough evaluation of Sidra Medicine’s Advanced Imaging Core, which underscored the center’s superior imaging abilities, operational excellence, scientific acumen, and capacity for offering advanced training and knowledge dissemination.

Moreover, the facility was acknowledged for its support of intricate imaging tasks, research-quality publications, and cooperative biomedical endeavors.

Professor Khalid Fakhro, Chief Research Officer at Sidra Medicine, expressed pride in obtaining this prestigious recognition. He remarked that Sidra Medicine consistently invests in top-notch research tools and advanced testing facilities that are directly aligned with patient care and medical advancements.

He added that the recognition from ZEISS enhances Sidra Medicine's objective to refine diagnostics and deepen the understanding of complex and rare conditions, ultimately contributing to more accurate treatments and improved health outcomes for patients.